EnBio Holdings (TSE:6092) Cyclically Adjusted Revenue per Share: 円1,333.98 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6092 EnBio Holdings Inc TSE:6092
59 GF Score
Price 円751.00
GF Value 円803.01
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is EnBio Holdings Cyclically Adjusted Revenue per Share?

EnBio Holdings TSE:6092 +0.13% 59 Cyclically Adjusted Revenue per Share is 円1,333.98 as of Mar. 2026. GuruFocus rates TSE:6092 with a GF Score™ of 59/100 and a GF Value™ of 円803.01 (Fairly Valued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

EnBio Holdings's adjusted revenue per share for the three months ended in Mar. 2026 was 円435.717. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円1,333.98 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-07), EnBio Holdings's current stock price is 円751.00. EnBio Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was 円1,333.98. EnBio Holdings's Cyclically Adjusted PS Ratio of today is 0.56.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of EnBio Holdings was 0.63. The lowest was 0.45. And the median was 0.53.


EnBio Holdings  (TSE:6092) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

EnBio Holdings's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=751.00/1333.98
=0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of EnBio Holdings was 0.63. The lowest was 0.45. And the median was 0.53.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


EnBio Holdings Cyclically Adjusted Revenue per Share Related Terms


EnBio Holdings Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for EnBio Holdings's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EnBio Holdings Cyclically Adjusted Revenue per Share Chart

EnBio Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 1,135.45 0.00 1,333.98

EnBio Holdings Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1,245.97 1,265.01 1,305.55 1,333.98

TSE:6092 vs CTAS, CPRT, GPN: Cyclically Adjusted Revenue per Share Comparison

For the Specialty Business Services subindustry, EnBio Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EnBio Holdings Cyclically Adjusted PS Ratio vs Business Services Industry

For the Business Services industry and Industrials sector, EnBio Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where EnBio Holdings's Cyclically Adjusted PS Ratio falls into.


TSE:6092
59GF Score
EnBio Holdings Inc TSE:6092
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EnBio Holdings Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, EnBio Holdings's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=435.717/112.7000*112.7000
=435.717

Current CPI (Mar. 2026) = 112.7000.

EnBio Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201512 183.178 98.100 210.440
201603 127.394 97.900 146.653
201606 83.722 98.100 96.182
201609 228.289 98.000 262.532
201612 162.912 98.400 186.587
201703 495.820 98.100 569.612
201706 341.238 98.500 390.432
201709 417.430 98.800 476.158
201712 256.682 99.400 291.027
201803 389.104 99.200 442.057
201806 292.188 99.200 331.951
201809 312.215 99.900 352.219
201812 382.069 99.700 431.887
201903 313.776 99.700 354.690
201906 327.094 99.800 369.374
201909 320.714 100.100 361.084
201912 218.844 100.500 245.410
202003 249.631 100.300 280.493
202006 357.146 99.900 402.906
202009 188.182 99.900 212.293
202012 281.442 99.300 319.421
202103 202.820 99.900 228.807
202106 288.950 99.500 327.283
202109 359.288 100.100 404.513
202112 456.997 100.100 514.521
202203 247.941 101.100 276.389
202206 401.710 101.800 444.722
202209 446.637 103.100 488.225
202212 170.819 104.100 184.931
202303 203.157 104.400 219.308
202306 456.776 105.200 489.341
202309 253.010 106.200 268.496
202312 184.709 106.800 194.913
202403 318.220 107.200 334.547
202409 0.000 108.900 0.000
202503 0.000 111.100 0.000
202506 300.988 111.700 303.683
202509 400.617 112.000 403.121
202512 421.995 113.000 420.875
202603 435.717 112.700 435.717

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of 円1,333.98 mean?
EnBio Holdings (TSE:6092) has a Cyclically Adjusted Revenue per Share of 円1,333.98 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on EnBio Holdings and its competitors.
Is EnBio Holdings' Cyclically Adjusted Revenue per Share too high?
EnBio Holdings' current Cyclically Adjusted Revenue per Share is 円1,333.98. Overall, EnBio Holdings has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EnBio Holdings' Cyclically Adjusted Revenue per Share compare to CTAS and CPRT?
EnBio Holdings' Cyclically Adjusted Revenue per Share of 円1,333.98 can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Business Services company?
A good Cyclically Adjusted Revenue per Share depends on the Business Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on EnBio Holdings and its competitors. EnBio Holdings's current Cyclically Adjusted Revenue per Share is 円1,333.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EnBio Holdings stock overvalued right now?
Based on GuruFocus' analysis, EnBio Holdings (TSE:6092) is currently considered Fairly Valued. The stock's GF Value™ is 円803.01, compared to a current price of 円751.00 — trading 6.5% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is 円1,333.98. EnBio Holdings' overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For EnBio Holdings (TSE:6092), the current Cyclically Adjusted Revenue per Share is 円1,333.98 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EnBio Holdings (TSE:6092) Overvalued in 2026?

Based on GuruFocus' analysis, EnBio Holdings stock appears to be undervalued. The current stock price of 円751.00 is trading 6.5% below its estimated GF Value™ of 円803.01. GuruFocus considers EnBio Holdings to be Fairly Valued.

Key valuation signals for TSE:6092:

  • Cyclically Adjusted Revenue per Share: 円1,333.98
  • GF Value™: 円803.01 vs. price of 円751.00 (6.5% below fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the TSE:6092 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


EnBio Holdings Business Description

Address Tokyo Kandata cho 2-11 O-machi Takaku Building 3F, Chiyoda-ku, Tokyo, JPN
EnBio Holdings Inc is a Japanese company engaged in environmental solution business, tools and chemicals business, and brownfield revitalization business. The environmental business involves investigation, remediation and risk management consulting of contaminated soil and groundwater; Tools and chemicals business involves sales of chemicals used for environmental work such as site investigation and remediation; and brownfield revitalization business which involves purchasing and regeneration of brownfields. The objective of the company is solving soil and groundwater contamination issues.
59GF Score

Get the complete analysis for TSE:6092

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円751.00
Price
円803.01
GF Value